TY - JOUR
T1 - Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy
AU - Cerebral Palsy Research Network
AU - Lott, Emma
AU - Fehlings, Darcy
AU - Gelineau-Morel, Rose
AU - Kruer, Michael
AU - Mink, Jonathan W.
AU - Thomas, Sruthi P.
AU - Wisniewski, Steve
AU - Aravamuthan, Bhooma
N1 - Publisher Copyright:
© 2024 by the American Academy of Pediatrics.
PY - 2024/7
Y1 - 2024/7
N2 - Cerebral palsy (CP) is the most common childhood-onset motor disability and the most common condition associated with dystonia in young people.1,2 Dystonia is a debilitating movement disorder characterized by overflow muscle activation triggered by attempted voluntary movement.2,3 It is unclear which, if any, medications used to treat dystonia in CP are effective.3 To determine the effectiveness of existing medications for dystonia in CP,4 we must first establish which medications are currently used. In this study, we queried how physicians approach pharmacologic dystonia treatment in people with CP.
AB - Cerebral palsy (CP) is the most common childhood-onset motor disability and the most common condition associated with dystonia in young people.1,2 Dystonia is a debilitating movement disorder characterized by overflow muscle activation triggered by attempted voluntary movement.2,3 It is unclear which, if any, medications used to treat dystonia in CP are effective.3 To determine the effectiveness of existing medications for dystonia in CP,4 we must first establish which medications are currently used. In this study, we queried how physicians approach pharmacologic dystonia treatment in people with CP.
UR - http://www.scopus.com/inward/record.url?scp=85197960772&partnerID=8YFLogxK
U2 - 10.1542/peds.2023-065512
DO - 10.1542/peds.2023-065512
M3 - Article
C2 - 38836309
AN - SCOPUS:85197960772
SN - 0031-4005
VL - 154
JO - Pediatrics
JF - Pediatrics
IS - 1
M1 - e2023065512
ER -